Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Axial Biotherapeutics completes venture financing

    Axial raised $19.2 million in a series A round led by Longwood Fund and Domain Associates. Kairos Ventures, Heritage Medical Systems and high net worth investors also participated.Axial Biotherapeutics Inc., Boston, …

    Published on 12/5/2016
  • Beijing Novogene completes venture financing

    Novogene raised $75 million in a series B round led by CMB International, SDIC Innovation and Sigma Square Capital.Beijing Novogene Bioinformatics Technology Co. Ltd., Beijing, China

    Published on 12/5/2016
  • Bellerophon completes private placement

    Bellerophon raised $12 million through the sale of 17.1 million units at $0.70 in a private placement. Each unit comprises a share and a five-year warrant to purchase a share at $0.80. H.C. Wainwright is the placement …

    Published on 12/5/2016
  • BioPharmX completes follow-on

    BioPharmX raised $12.5 million through the sale of 31.5 million class A units at $0.35 and 1,515 class B units at $1,000 in a follow-on underwritten by Roth Capital Partners. Each class A unit comprises a share and a …

    Published on 12/5/2016
  • Cel-Sci completes private placement of common stock and warrants

    Cel-Sci raised $4.3 million through the sale of 34 million shares at $0.125. Investors also received five-year warrants to purchase up to 17 million shares at $0.20; six-month warrants to purchase up to 34 million …

    Published on 12/5/2016
  • Cellectar completes follow-on

    Cellectar raised $8 million through the sale 800,000 common shares at $1.50 and 68 shares of series A convertible preferred stock at $100,000 per share in follow-on underwritten by Ladenburg Thalmann and Aegis Capital. …

    Published on 12/5/2016
  • dMed completes venture financing

    dMed raised $8 million in its first venture round led by from Qiming Venture Capital. Tairui Investment and Zai Lab Ltd. (Shanghai, China) also participated.dMed Co. Ltd., Shanghai, China

    Published on 12/5/2016
  • Essa Pharma completes debt financing

    Essa drew down $8 million from a new $10 million term loan facility from Silicon Valley Bank. The loan bears interest at 3% plus the prime rate and matures on Sept. 1, 2020. The remaining tranche of $2 million is …

    Published on 12/5/2016
  • Galera Therapeutics completes venture financing

    Galera raised an additional $15 million in a series B round from new investor Sofinnova Ventures, bringing the total raised in the round to $57 million.Galera Therapeutics Inc., Malvern, Pa.

    Published on 12/5/2016
  • Impel NeuroPharma completes venture financing

    Impel raised $21 million in the first tranche of a planned $36 million series C round from new investors venBio, 5AM Ventures and Vivo Capital. The company is eligible to receive another $15 million subject to …

    Published on 12/5/2016
  • Innovent completes venture financing

    Innovent raised $260 million in a series D round led by new investor Future Industry Investment Fund. New investors China Life Private Equity, Milestone, Ping An Ventures and Taikang Insurance Group and existing …

    Published on 12/5/2016
  • Kymab completes venture financing

    Kymab raised $100 million in a series C round led by new investors ORI Healthcare Fund and Shenzhen Hepalink Pharmaceutical Co. Ltd. (SZSE:002399, Shenzhen, China). Existing investors Wellcome Trust, the Bill & …

    Published on 12/5/2016
  • MetaboGen completes venture financing

    MetaboGen raised SEK4 million ($431,600) in the third and final investment from BioGaia, bringing the total raised by MetaboGen from the investor to SEK12 million ($1.4 million).MetaboGen AB, Gothenburg, Sweden

    Published on 12/5/2016
  • Nohla completes venture financing

    Nohla raised $43.5 million in a series A round led by new investor Arch Venture Partners. New investor 5AM Ventures and existing investor Jagen Group also participated.Nohla Therapeutics Inc., Seattle, Wash.

    Published on 12/5/2016
  • Oxford BioDynamics completes placing

    Oxford BioDynamics raised 7.1 million ($8.8 million) through the sale of 4.5 million shares at 158p in a placing and listing on the London Stock Exchanges AIM. The company is slated to begin trading on Dec. 6 under the …

    Published on 12/5/2016
  • OxThera completes venture financing

    OxThera raised 32 million ($34.1 million) in a round co-led by LSP, Ysios Capital, Sunstone Capital and Flerie Invest. Existing investors Kurma Partners, Idinvest Partners, Stiftelsen Industrifonden and Brohuvudet also …

    Published on 12/5/2016
  • Palatin completes follow-on

    Palatin raised $16.5 million through the sale of 25.4 million units at $0.65 in a follow-on underwritten by Canaccord, Roth Capital Partners and Chardan Capital Markets. Each unit comprises a share and a five-year …

    Published on 12/5/2016
  • Paradigm completes venture financing

    Paradigm Diagnostics raised about $3.5 million in a first close of a planned $7 million series B round led by Mesa Verde Venture Partners.Paradigm Diagnostics Inc., Phoenix, Ariz.

    Published on 12/5/2016
  • Q BioMed completes private placement of convertible debentures

    Q BioMed raised $1.5 million in debentures in the first tranche of a planned $4 million private placement. The debentures bear interest at 5% and convert at the lower of $4 or a 7% discount to the market, with a floor …

    Published on 12/5/2016
  • Rosetta Genomics completes direct public offering and private placement

    Rosetta raised $5 million in a registered direct offering of shares and convertible debentures and a concurrent private placement of unregistered convertible debentures and warrants. The company raised $547,500 through …

    Published on 12/5/2016
  • SQZ completes venture financing

    SQZ raised an additional $8 million in a series B round, bringing the total raised in the round to $24 million. GV and Quark Ventures participated.SQZ Biotechnologies Co., Watertown, Mass.

    Published on 12/5/2016
  • Tetra completes venture financing

    Tetra raised $5 million in a series A round co-led by Apjohn Group and Grand Angels. Dolby Family Ventures, the Alzheimers Drug Discovery Foundation and other private investors participated. The company also converted $…

    Published on 12/5/2016
  • Themis Bioscience completes venture financing

    Themis raised 10 million ($10.6 million) in a series B round led by existing investor Wellington Partners. Existing investors Ventech and Omnes Capital and new investor aws Grnderfonds participated, along with new …

    Published on 12/5/2016
  • TraceLink completes venture financing

    TraceLink raised $51.5 million in a series C round led by Goldman Sachs Growth Equity. FirstMark Capital, Volition Capital and F-Prime Capital also participated.TraceLink Inc., North Reading, Mass.

    Published on 12/5/2016
  • Tracon completes follow-on

    Tracon raised $17.4 million through the sale of 3 million shares at $5.75 in a follow-on underwritten by Jefferies, Stifel and BTIG. The figures include the sale of a 393,750 share overallotment.Tracon Pharmaceuticals …

    Published on 12/5/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993